Therefore, we suggest that the genetic interaction and protein haploinsufficiency of SPG11 and SYNJ1, both proteins implicated in common biochemical pathways, cause clinical spastic paraplegia of late onset. Here, SPG11 is linked to Spastic paraplegia.